Fosfo-Lamine A/C (Ser22) Antilichaam

9007-83-4

[LMNA]

4000

Human, Mouse, Rat

Store at -20 degree C. Stable for 12 months from date of receipt.

Phospho-Lamin A/C (Ser22) Antibody detects endogenous levels of Lamin A/C only when phosphorylated at Ser22.<br>Tissue Specificity: In the arteries, prelamin-A/C accumulation is not observed in young healthy vessels but is prevalent in medial vascular smooth muscle cells (VSMCs) from aged individuals and in atherosclerotic lesions, where it often colocalizes with senescent and degenerate VSMCs. Prelamin-A/C expression increases with age and disease. In normal aging, the accumulation of prelamin-A/C is caused in part by the down-regulation of ZMPSTE24/FACE1 in response to oxidative stress.

[LMNA; LMNA; FPL; IDC; LFP; CDDC; EMD2; FPLD; HGPS; LDP1; LMN1; LMNC; PRO1; CDCD1; CMD1A; FPLD2; LMNL1; CMT2B1; LGMD1B; LMN1]

[Lamin A/C]

[lamin isoform D; Prelamin-A/C; lamin; 70 kDa lamin; prelamin-A/C; lamin A/C-like 1; renal carcinoma antigen NY-REN-32; lamin A/C; 70 kDa lamin; Renal carcinoma antigen NY-REN-32]

383792150

NP_001244303.1

NM_001257374.1

P02545